Of note, an ex-vivo sampling only displays tumor biology and receptor expression in the respective lesion, while assessment of the in-vivo CXCR4 expression offers a non-invasive whole-body evaluation, which reflects also possible intraindividual tumor heterogeneity. Here, CXCR4 is linked to neoplasm.